| Novel mutant of Escherichia coli asparaginase II to reduction of the glutaminase activity in treatment of acute lymphocytic leukemia by molecular dynamics simulations and QM-MM … N Ardalan, S Mirzaie, AA Sepahi, RA Khavari-Nejad Medical hypotheses 112, 7-17, 2018 | 46 | 2018 |
| Molecular docking and binding study of harpagoside and harpagide as novel anti-inflammatory and anti-analgesic compound from Harpagophytum procumbens based on their … A Rahimi, K Razmkhah, M Mehrnia, A Mohamadnia, H Sahebjamee, ... Asian Pacific Journal of Tropical Disease 6 (3), 227-231, 2016 | 25 | 2016 |
| Blockage of the monoamine oxidase by a natural compound to overcome Parkinson’s disease via computational biology M Sherafatizangeneh, C Farshadfar, N Mojahed, A Noorbakhsh, ... Journal of Computational Biophysics and Chemistry 21 (03), 373-387, 2022 | 16 | 2022 |
| Development of Escherichia coli asparaginase II for the Treatment of Acute Lymphocytic Leukemia: In Silico Reduction of asparaginase II Side Effects by a Novel Mutant (V27F) N Ardalan, A Akhavan Sepahi, RA Khavari-Nejad Asian Pacific Journal of Cancer Prevention 22 (4), 1137-1147, 2021 | 15 | 2021 |
| Designing a natural inhibitor against human kynurenine aminotransferase type II and a comparison with PF-04859989: a computational effort against schizophrenia A Noorbakhsh, E Hosseininezhadian Koushki, C Farshadfar, N Ardalan Journal of Biomolecular Structure and Dynamics 40 (15), 7038-7051, 2022 | 13 | 2022 |
| Prevention of SARS-CoV-2 proliferation with a novel and potent main protease inhibitor by docking, ADMET, MM-PBSA, and molecular dynamics simulation A Noorbakhsh, RH Askandar, MS Alhagh, C Farshadfar, SH Seyedi, ... Journal of Computational Biophysics and Chemistry 20 (03), 305-322, 2021 | 10 | 2021 |
| Prevalence of human T-lymphotropicvirus types I&II among high risk groups in Sanandaj in 2010. N Ardalan, M Abdi, BR Zarif, A Amini, F Memary, E Haydari, A Ahmadi | 8 | 2013 |
| The SARS-Cov-2 Proliferation blocked by a novel and potent main protease inhibitor via computer-aided drug design S Shayan, S Jamaran, RH Askandar, A Rahimi, A Elahi, C Farshadfar, ... Iranian Journal of Pharmaceutical Research: IJPR 20 (3), 399, 2021 | 7 | 2021 |
| Structural screening into the recognition of a potent inhibitor against non-structural protein 16: a molecular simulation to inhibit SARS-CoV-2 infection SH Seyedi, MS Alhagh, M Ahmadizad, N Ardalan, ... Journal of Biomolecular Structure and Dynamics 40 (24), 14115-14130, 2022 | 4 | 2022 |
| Risk factors associated with community-acquired CTX-M producing Klebsiella pneumoniae typing by Rep-PCR in Sanandaj, Iran N Ardalan, S Jamaran, F Memari, K Davari, B Rostami, R Ramazanzadeh Biotech Res Asia 13 (3), 1311-7, 2016 | 2 | 2016 |
| Early Blockage of Mycobacterium Tuberculosis Cell-wall Synthesis via EchA\6 Inhibition to Overcome Resistance Strain: Insights from Umbrella Sampling Simulations RH Askandar, F Sharifi, S Shayan, H Mohammadi, A Rahimi, N Ardalan, ... Current Bioactive Compounds 19 (10), 2-17, 2023 | | 2023 |
Arian RahimiVerified email at fardavar.org
